Log in
0 followers
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
Industries
Headquarters
Stage
Employees
Links
Scott Clarke
11 members
4 members
3 members
1 members
BioMarin Pharmaceutical
22 followers
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Verve Therapeutics
53 followers
Discover companies